tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DMAC Stock Latest News

DiaMedica Therapeutics initiated with a Buy at TD Cowen
The FlyDiaMedica Therapeutics initiated with a Buy at TD Cowen
9d ago
DMAC
Buy Rating for Diamedica Therapeutics: Promising Potential of DM199 in Preeclampsia Treatment
PremiumRatings
Buy Rating for Diamedica Therapeutics: Promising Potential of DM199 in Preeclampsia Treatment
9d ago
DMAC
ReMEDy2 Trial: A Potential Game-Changer for Acute Ischemic Stroke Treatment
PremiumCompany Announcements
ReMEDy2 Trial: A Potential Game-Changer for Acute Ischemic Stroke Treatment
11d ago
DMAC
DiaMedica Therapeutics’ Earnings Call Highlights Progress and Challenges
PremiumCompany Announcements
DiaMedica Therapeutics’ Earnings Call Highlights Progress and Challenges
2M ago
DMAC
Buy Rating for Diamedica Therapeutics Driven by Promising Phase 2 Results of DM199 in Preeclampsia
PremiumRatings
Buy Rating for Diamedica Therapeutics Driven by Promising Phase 2 Results of DM199 in Preeclampsia
3M ago
DMAC
DiaMedica Therapeutics Advances with Positive Trials and Funding
PremiumCompany AnnouncementsDiaMedica Therapeutics Advances with Positive Trials and Funding
3M ago
DMAC
DiaMedica Therapeutics Enters Sales Agreement with TD Securities
Premium
Company Announcements
DiaMedica Therapeutics Enters Sales Agreement with TD Securities
3M ago
8K
DMAC
DiaMedica Therapeutics files $100M mixed securities shelf
Premium
The Fly
DiaMedica Therapeutics files $100M mixed securities shelf
3M ago
DMAC
DiaMedica Therapeutics reports Q2 EPS (18c), consensus (19c)
PremiumThe Fly
DiaMedica Therapeutics reports Q2 EPS (18c), consensus (19c)
3M ago
DMAC
DMAC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
DMAC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
DMAC
DiaMedica Therapeutics CMO Lorianne Masuoka resigns, Julie Krop succeeds
PremiumThe Fly
DiaMedica Therapeutics CMO Lorianne Masuoka resigns, Julie Krop succeeds
3M ago
DMAC
PRTC
DiaMedica Appoints New Chief Medical Officer
PremiumCompany Announcements
DiaMedica Appoints New Chief Medical Officer
3M ago
8K
DMAC
DiaMedica Therapeutics files to sell 8.61M common shares for holders
PremiumThe FlyDiaMedica Therapeutics files to sell 8.61M common shares for holders
3M ago
DMAC
ReMEDy2 Trial: A New Hope for Acute Ischemic Stroke Treatment?
Premium
Company Announcements
ReMEDy2 Trial: A New Hope for Acute Ischemic Stroke Treatment?
3M ago
DMAC
DiaMedica Therapeutics Secures $30.1 Million in Private Placement
Premium
Company Announcements
DiaMedica Therapeutics Secures $30.1 Million in Private Placement
4M ago
DMAC
DiaMedica Therapeutics to sell 8.606M shares at $3.50 in private placement
PremiumThe Fly
DiaMedica Therapeutics to sell 8.606M shares at $3.50 in private placement
4M ago
DMAC
DiaMedica Announces $30.1M Private Placement for DM199
PremiumCompany Announcements
DiaMedica Announces $30.1M Private Placement for DM199
4M ago
8K
DMAC
DiaMedica Therapeutics price target raised to $11 from $8 at Craig-Hallum
PremiumThe Fly
DiaMedica Therapeutics price target raised to $11 from $8 at Craig-Hallum
4M ago
DMAC
DiaMedica Therapeutics price target raised to $14 from $11 at Lake Street
PremiumThe Fly
DiaMedica Therapeutics price target raised to $14 from $11 at Lake Street
4M ago
DMAC
DiaMedica Therapeutics price target raised to $12 from $10 at H.C. Wainwright
PremiumThe FlyDiaMedica Therapeutics price target raised to $12 from $10 at H.C. Wainwright
4M ago
DMAC
DiaMedica Announces Positive Interim Results for DM199 Study
Premium
Company Announcements
DiaMedica Announces Positive Interim Results for DM199 Study
4M ago
8K
DMAC
DiaMedica Therapeutics reports interim results from DM199 study
Premium
The Fly
DiaMedica Therapeutics reports interim results from DM199 study
4M ago
DMAC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >